ScholarIQanswers from OpenAlex

Telemedicine application in patients with chronic disease: a systematic review and meta-analysis

PaperCitations, authors & open-access status

Telemedicine application in patients with chronic disease: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Telemedicine application in patients with chronic disease: a systematic review and meta-analysis have?

ScholarIQcitation count

Telemedicine application in patients with chronic disease: a systematic review and meta-analysis has 160 citations in the OpenAlex counts ScholarIQ stores.

When was Telemedicine application in patients with chronic disease: a systematic review and meta-analysis published?

ScholarIQyear

Telemedicine application in patients with chronic disease: a systematic review and meta-analysis has 2022 year in the ScholarIQ index.

What is the open-access status of Telemedicine application in patients with chronic disease: a systematic review and meta-analysis?

ScholarIQoa status

Telemedicine application in patients with chronic disease: a systematic review and meta-analysis has gold oa status in the ScholarIQ index.

What is the DOI of Telemedicine application in patients with chronic disease: a systematic review and meta-analysis?

ScholarIQdoi

The DOI for Telemedicine application in patients with chronic disease: a systematic review and meta-analysis is on the source record.

What is the PMID of Telemedicine application in patients with chronic disease: a systematic review and meta-analysis?

ScholarIQpmid

The PMID for Telemedicine application in patients with chronic disease: a systematic review and meta-analysis is on the source record.

What is the OpenAlex record for Telemedicine application in patients with chronic disease: a systematic review and meta-analysis?

ScholarIQopenalex

The OpenAlex for Telemedicine application in patients with chronic disease: a systematic review and meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial